Dietary alkali and bicarbonate therapy may improve bicarbonate status and may slow progression in selected patients, but treatment must account for sodium load, potassium, edema, blood pressure and medications
Any change runs through formal rulemaking that could take many months
Novo Nordisk asserts that advertising compounded semaglutide with Ozempic and Wegovy causes confusion in patients and implies that Novo Nordisk sponsors those compounded drugs or supplies the base ingredient, semaglutide, to facilities that are making them
GLP-1 and cardiovascular health in women Research suggests GLP-1 medications may offer cardiovascular benefits, which is particularly relevant for women after menopause when heart disease risk increases
GLP-1RA and DPP-4 inhibitors are useful in the management of patients with T2DM over the spectrum of HbA1c levels, including drug nave patients as well as those treated with other glucose lowering therapies